• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share

Testimony from Alex M. Azar II on Secretary Azar's Oral Testimony on the President's FY 2021 Budget before The United States Senate Committee on Appropriations

Secretary Azar's Oral Testimony on the President's FY 2021 Budget
The United States Senate Committee on Appropriations
Tuesday, February 25, 2020 - 10:30

As Prepared for Delivery

Chairman Blunt, Ranking Member Murray, thank you for inviting me to discuss the President's Budget for Fiscal Year 2021.

I am honored to appear before this committee for budget testimony as HHS Secretary for the third time, especially after the remarkable year of results that the HHS team has produced. With support from this committee, this past year, we saw the number of drug overdose deaths decline for the first time in decades; another record year of generic drug approvals from FDA; and historic drops in Medicare Advantage, Medicare Part D, and exchange premiums.

The President's Budget aims to move toward a future where HHS programs work better for the people we serve; where our human services programs put people at the center; and where America's healthcare system is affordable, personalized, puts patients in control, and treats you like a human being, not a number.

HHS has the largest discretionary budget of any non-defense department, which means that difficult decisions must be made to put discretionary spending on a sustainable path.

This committee has made important investments over the years in some of HHS's large discretionary programs, including at the National Institutes of Health, and we're grateful for that work.

The President's Budget proposes to protect what works in our healthcare system and make it better. I'll mention two ways we do that: first, facilitating patient-centered markets, and, second, tackling key, impactable health challenges.

The Budget's healthcare reforms aim to put the patient at the center. It would, for instance, eliminate cost-sharing for colonoscopies, a life-saving preventive service. We would reduce patients' costs and promote competition by paying the same for certain services regardless of setting, and the Budget endorses bipartisan, bicameral drug pricing legislation. These reforms will improve Medicare and extend the life of the hospital insurance fund by at least 25 years.

We propose investing $116 million in HHS's initiative to reduce maternal mortality and morbidity, and we propose reforms to tackle America's rural health crisis, including telehealth expansions and new flexibility for rural hospitals. The Budget increases investments to combat the opioid epidemic, including SAMHSA's State Opioid Response program, and we appreciate this committee's work with us to give states flexibility in that program to address stimulants like methamphetamines.

We request $716 million for the President's initiative to end the HIV epidemic in America by using effective, evidence-based tools. Thanks to funding appropriated by this committee, we've already begun implementing this initiative.

The Budget reflects how seriously we take the threat of other infectious diseases, such as the China coronavirus, by prioritizing funding for CDC's infectious disease programs and maintaining investments in hospital preparedness.

We now have 14 cases of the China coronavirus detected in the United States, involving travel to China or close contacts with travelers; 3 cases among Americans repatriated from Wuhan; and 40 cases among American passengers repatriated from the Diamond Princess.

While the immediate risk to individual members of the American public remains low, there is now community transmission in a number of countries, including outside of Asia, which is deeply concerning.

We are working closely with state, local, and private sector partners to prepare for mitigating the virus's potential spread in the United States, as we will likely see more cases here.

Today, NIH will announce the launch of the first U.S. clinical trial for an investigational antiviral, at the University of Nebraska Medical Center.

Yesterday, OMB sent a request to make $2.5 billion in funding available for preparedness and response, including for therapeutics, vaccines, personal protective equipment, state and local support, and surveillance. I look forward to working closely with Congress on that.

Lastly, when it comes to human services, the Budget cuts back on programs that lack proven results, while reforming programs like TANF to drive state investments in supporting work and the benefits it brings for well-being. We continue the FY 2020 investments Congress made in Head Start and child-care programs, which promote children's well-being and adults' independence.

This year's Budget aims to protect and enhance Americans' well-being and deliver Americans a more affordable, personalized healthcare system that works better, rather than just spends more. I look forward to working with this committee to make that commonsense goal a reality.

Content created by Assistant Secretary for Legislation (ASL)
Content last reviewed on February 28, 2020